Tag: Valneva
Valneva: renewal of the mandates of the members of the management board – 03/16/2022 at 18:11
(AOF) – Valneva announced Wednesday evening that its supervisory board had renewed the mandates of the members of the management board for an additional period of three years which will…
Valneva: successful phase 3 trial in chikungunya – 03/08/2022 at 08:51
(CercleFinance.com) – Valneva announces the success of the pivotal phase 3 trial of its single-shot chikungunya vaccine candidate, VLA1553, with its positive final analysis including six-month follow-up data confirming the…
Valneva up sharply after the success of its chikungunya vaccine – 03/08/2022 at 11:00 am
Valneva’s chikungunya program received “Breakthrough Therapy” status from the FDA in July 2021. (Photo credits: Valneva Group – ) (AOF) – Valneva jumped 6.75% to 13.6 euros. The Phase 3…
Covid-19: the Franco-Austrian vaccine Valneva obtains its first authorization in Bahrain
Bahrain authorized this Tuesday the emergency use of the vaccine against Covid-19 developed by the Franco-Austrian laboratory Valneva. Obtaining the inactivated and adjuvanted vaccine from Valneva, dubbed “VLA2001”, follows a…
Valneva Receives CHMP Assessment for its Inactivated COVID-19 Vaccine Candidate
By Alexandra Saintpierre Published on 02/25/2022 at 07:43 (Boursier.com) — Valneva…
Valneva and Pfizer: New Positive Lyme Disease Vaccine Data
PARIS (Agefi-Dow Jones)–The biotechnology company Valneva and the American laboratory Pfizer announced on Friday new positive phase 2 results for their candidate vaccine against Lyme disease, VLA15. “Based on these…
Abnormal volumes in today’s session: Open Group, Valneva
During this trading session on Thursday February 3, 2022, abnormal trading volumes were detected on the French market. Today, it is the Groupe Open share that stands out, with trading…
Anti-Covid vaccine: Valneva starts its phase 3 clinical trial as a booster dose
The Franco-Austrian laboratory is seeking to develop a booster dose compatible with a primary vaccination carried out with a vaccine other than its own. The Franco-Austrian laboratory Valneva, which is…
Notable trades of the day: Soitec Silicon, Valneva
During this trading session on Thursday January 20, 2022, abnormal trading volumes were detected on the French market. Today, it is the Soitec Silicon share that stands out, with trading…
Unusual volumes on the stock market today: Suez Environnement, Valneva
During this trading session on Wednesday January 19, 2022, abnormal trading volumes were detected on the French market. Today, it is the Suez Environnement share that stands out, with trading…
Valneva: its inactivated vaccine candidate shows neutralization of the Omicron variant – 01/20/2022 at 09:25
(Photo credits: Valneva Group – ) (AOF) – Valneva announced the results of a preliminary laboratory study which demonstrated that antibodies from the serum of people vaccinated with three doses…
Valneva in sharp decline, Europe would wait for additional data on the anti-Covid vaccine
According to information from the Reuters agency, the European Union is still awaiting additional data concerning the biotech’s anti-Covid vaccine. Valneva down sharply, Europe awaiting additional data on Covid vaccine…